Co-Diagnostics (CODX) vs NexGel (NXGL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
NexGel is the larger company by market cap ($1.7 million vs $1.4 million), about 1.2 times the size. NexGel converts more of its revenue into profit, with a net margin of -26.3% versus -7533.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CODX | NXGL |
|---|---|---|
| Share price | $0.1295 | $3.12 |
| Market cap | $1.36M | $1.67M |
| 1-day change | -21.32% | -6.84% |
| EPS (TTM) | $-21.71 | $-15.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $622.49K | $11.42M |
| Revenue growth (YoY) | -84.10% | +31.46% |
| Net income (latest FY) | $-46.90M | $-3.00M |
| Gross margin | 64.28% | 39.48% |
| Operating margin | -8058.83% | -29.35% |
| Net margin | -7533.62% | -26.27% |
| 52-week high | $13.54 | $40.40 |
| 52-week low | $0.1276 | $3.00 |
| Distance from 52-week high | -99.04% | -92.27% |
| Analyst consensus | none | hold |
| Avg. price target upside | +2988.80% | — |
| Average volume | 2.03M | 112.24K |
| Shares outstanding | 10.51M | 536.11K |
| Employees | 115 | 19 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NexGel is more profitable, keeping -26.3 cents of every revenue dollar as net income versus -7533.6 cents for Co-Diagnostics.
- NexGel grew revenue faster in its latest fiscal year (+31.46% vs -84.10%).
About Co-Diagnostics
CODX stock →Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.
Health Care · Medical/Dental Instruments · 115 employees
About NexGel
NXGL stock →NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.
Health Care · Medical/Dental Instruments · 19 employees
CODX vs NXGL FAQ
Which is bigger, Co-Diagnostics or NexGel?
NexGel (NXGL) is larger, with a market capitalization of $1.67M compared with $1.36M for Co-Diagnostics (CODX).
Are Co-Diagnostics and NexGel in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.